Core Viewpoint - The management buyout led by Wei Naixu marks a pivotal turning point for Sichuang Medical (300078.SZ), which has been without a controlling shareholder for nearly six years. This change is expected to end the long-standing "no actual controller" situation, although the company still faces significant challenges, including ongoing losses and the repercussions of past financial misconduct [1][3][5]. Group 1: Background of the Company - Sichuang Medical has been in a state of "no actual controller" since December 2019, following the dissolution of the agreement between the former actual controller and specific investors [3]. - Despite attempts to change this situation, such as the temporary establishment of a major shareholder in 2021, the company has not achieved a stable controlling position until the recent management buyout plan [3][4]. Group 2: Management Buyout Details - Wei Naixu is the key driver of the management buyout, utilizing a combination of share transfer, voting rights delegation, and integration of concerted actions to facilitate the acquisition [3][4]. - After the buyout, Wei Naixu's direct and indirect shareholding will total 7.47%, with actual voting rights reaching 13.18%. If successful, this will make him the controlling shareholder [4]. Group 3: Financial Challenges - The company has faced continuous losses since 2020, with a cumulative net profit loss exceeding 3 billion yuan over five years [5][6]. - The financial situation has improved slightly in 2025, with a revenue of 604 million yuan, a year-on-year increase of 6.95%, and a significant reduction in net loss by 98.32% [7]. - However, the revenue growth is primarily attributed to asset sales rather than core business performance, indicating that the foundation for a sustainable turnaround remains weak [7]. Group 4: Market Reaction - The capital market has responded positively to the management buyout, as evidenced by a 20% surge in stock price following the announcement, reflecting optimistic expectations for the change in control [1][7].